Opthea Limited (OPT) is a biotechnology company focused on development of new drugs for the treatment of eye diseases. Opthea’s lead asset, OPT – 302, is a soluble form of VEGFR-3 in clinical development as a novel therapy for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Wet AMD and DME are causes of blindness in the elderly and diabetic populations respectively and are increasing in prevalence worldwide.
Opthea Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.opthea.com.
You can also check out dividend history for similar stocks in the same sector as follows:
OPT Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found